| scholarly article | Q13442814 |
| P50 | author | John Endicott | Q59753101 |
| Jeremy J Kodanko | Q89554599 | ||
| P2093 | author name string | Izabela Podgorski | |
| Karan Arora | |||
| Jacob P Kodanko | |||
| Mackenzie Herroon | |||
| Marim Alnaed | |||
| Matthew Huisman | |||
| P2860 | cites work | Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis | Q24314942 |
| Cysteine cathepsins: from structure, function and regulation to new frontiers | Q26860406 | ||
| Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex | Q27620728 | ||
| Irreversible inhibitors of serine, cysteine, and threonine proteases | Q28217093 | ||
| The crystal structure of human cathepsin L complexed with E-64 | Q28237390 | ||
| Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase | Q29617738 | ||
| Photodynamic quenched cathepsin activity based probes for cancer detection and macrophage targeted therapy. | Q30411275 | ||
| Targeting proteases: successes, failures and future prospects | Q34563752 | ||
| Structure-based development of specific inhibitors for individual cathepsins and their medical applications | Q34598268 | ||
| Multiple roles for cysteine cathepsins in cancer | Q35946770 | ||
| Cathepsin L targeting in cancer treatment. | Q36218199 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| Cysteine cathepsins: cellular roadmap to different functions | Q36934250 | ||
| Cysteine cathepsin proteases as pharmacological targets in cancer | Q37013943 | ||
| Improved quenched fluorescent probe for imaging of cysteine cathepsin activity | Q37304778 | ||
| Application of metal coordination chemistry to explore and manipulate cell biology | Q37387617 | ||
| Targeting proteins with metal complexes | Q37395822 | ||
| Cathepsin L, target in cancer treatment? | Q37643875 | ||
| Development of nitrile-based peptidic inhibitors of cysteine cathepsins | Q37694669 | ||
| Cathepsins and their involvement in immune responses | Q37774592 | ||
| Cysteine proteases as targets for metal-based drugs | Q37808955 | ||
| Metal-based antimicrobial protease inhibitors | Q38091536 | ||
| Luminescent Rhenium(I) and Iridium(III) Polypyridine Complexes as Biological Probes, Imaging Reagents, and Photocytotoxic Agents | Q38297726 | ||
| Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response | Q38644547 | ||
| A luminescent and biocompatible photoCORM. | Q39257040 | ||
| Inhibition of the cathepsin cysteine proteases B and K by square-planar cycloaurated gold(III) compounds and investigation of their anti-cancer activity | Q39560742 | ||
| Structure-based development of cathepsin L inhibitors and therapeutic applications for prevention of cancer metastasis and cancer-induced osteoporosis. | Q40717671 | ||
| Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice. | Q42273053 | ||
| Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition | Q42380738 | ||
| Accelerated hole transfer across a molecular double barrier. | Q42926847 | ||
| CO Releasing Properties and Cytoprotective Effect of cis-trans- [ReII(CO)2Br2L2]n Complexes | Q42944338 | ||
| Legumain and cathepsin-L expression in human unstable carotid plaque. | Q43293933 | ||
| Ruthenium bis-diimine complexes with a chelating thioether ligand: delineating 1,10-phenanthrolinyl and 2,2'-bipyridyl ligand substituent effects. | Q43999034 | ||
| Metal compounds for the treatment of parasitic diseases | Q45192577 | ||
| Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. | Q46006433 | ||
| A Theranostic Two-Tone Luminescent PhotoCORM Derived from Re(I) and (2-Pyridyl)-benzothiazole: Trackable CO Delivery to Malignant Cells | Q46084330 | ||
| Metal complexes as enzyme inhibitors | Q46308676 | ||
| Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents. | Q46395388 | ||
| Inhibition of cathepsin L by epoxysuccinyl peptides simultaneously addressing active-site and remote-site regions | Q46541903 | ||
| Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue. | Q52979432 | ||
| Modified biovectors for the tuneable activation of anti-platelet carbon monoxide release. | Q53229356 | ||
| A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction. | Q53260791 | ||
| Cathepsin L in glioma progression: comparison with cathepsin B. | Q55471045 | ||
| Influence of Donor–Acceptor Distance Variation on Photoinduced Electron and Proton Transfer in Rhenium(I)–Phenol Dyads | Q59161408 | ||
| Cysteine Proteases and Their Inhibitors | Q61066438 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| Rhenium inhibitors of cathepsin B (ReO(SYS)X (where Y = S, py; X = Cl, Br, SPhOMe-p)): Synthesis and mechanism of inhibition | Q80126956 | ||
| Emissive behavior, cytotoxic activity, cellular uptake, and PEGylation properties of new luminescent rhenium(I) polypyridine poly(ethylene glycol) complexes | Q85579887 | ||
| Modification of 1,2,4,5-tetrazine with cationic rhenium(I) polypyridine units to afford phosphorogenic bioorthogonal probes with enhanced reaction kinetics | Q86612046 | ||
| Thermal and photochemical reactivity of manganese tricarbonyl and tetracarbonyl complexes with a bulky diazabutadiene ligand | Q87579897 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7881-7891 | |
| P577 | publication date | 2018-06-08 | |
| P1433 | published in | Inorganic Chemistry | Q902828 |
| P1476 | title | Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L. | |
| P478 | volume | 57 |
| Q57046763 | Catch and Release Photosensitizers: Combining Dual Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers | cites work | P2860 |
Search more.